Answers are grounded in this paper and cite their sources.
Evaluate the effect of combined local and systemic therapy with mesenchymal stem cells (MSCs) on the immunophenotypic profile (IPT) of peripheral blood mononuclear cells (PBMCs) in patients after liver transplantation. Materials and methods: In a randomized prospective study, 30 patients received MSC therapy, while 30 patients were on standard immunosuppressive therapy. IPT of PBMCs was performed using multicolor flow cytometry. Functional parameters of the graft, tacrolimus concentration, morphological signs of rejection, and clinical outcomes were evaluated. The MSC group showed faster functional recovery of the graft with accelerated decrease in ALT levels on days 7 and 10 (p< 0.05) with significantly lower tacrolimus concentration throughout the observation period. The frequency of immune-mediated graft dysfunction in both groups was 20%; however, the MSC group showed a lower rejection activity index (RAI 6 (4; 7) versus 7 (4; 8) points) and no cases of humoral rejection. IPT revealed a decrease in the absolute number of CD16+56+ natural killer cells, CD3+CD4+ and CD3+CD8+ effector memory T cells, naive mature B lymphocytes, and marginal zone B cells, with increased levels of myeloid and plasmacytoid dendritic cells and immunosuppressive B1a lymphocytes in the MSC group.
No takes yet. Share an insight, caveat, or question.
В. et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: